J Korean Med Sci.  2022 Jun;37(22):e187. 10.3346/jkms.2022.37.e187.

It Is Time to Consider Human Leukocyte Antigen Compatibility in Lung Transplantation

• Rhee CK

• KMID: 2530423
• DOI: http://doi.org/10.3346/jkms.2022.37.e187

Reference

1. Jeong YH, Kim DK, Choi S. Current status of lung transplantation in Korea. Curr Chall Thorac Surg. 2022; 4:4.

2. Smith JD, Ibrahim MW, Newell H, Danskine AJ, Soresi S, Burke MM, et al. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation. J Heart Lung Transplant. 2014; 33(10):1074–1082. PMID: 24954882.

3. Brugière O, Suberbielle C, Thabut G, Lhuillier E, Dauriat G, Metivier AC, et al. Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay. Transplantation. 2013; 95(5):761–765. PMID: 23296148.

4. Dick A, Humpe A, Kauke T. Impact, screening, and therapy of HLA antibodies in patients before and after lung transplantation. Transfus Med Hemother. 2019; 46(5):337–347. PMID: 31832059.

5. Kim HE, Yang YH, Paik HC, Jeong SJ, Kim SY, Park MS, et al. The assessment and outcomes of crossmatching in lung transplantation in Korean patients. J Korean Med Sci. 2022; 37(22):e177.